In 2024, Finland leads in musculo-skeletal system medicine use, with 100.8 units per thousand persons per day. Estonia and Portugal follow with 92.6 and 88.8 units respectively. South Korea shows the highest year-on-year increase at 3.73% in 2023, followed by Estonia at 2.99%. Chile exhibited a notable surge with a 15.63% increase. In contrast, Portugal and Slovakia saw declines of 1.15% and 1.55% respectively. Canada and Israel ranked lowest in usage with minimal increases. The five-year CAGR highlights overall growth, primarily driven by emerging economies adapting aggressive healthcare interventions.
Future trends to monitor include:
- Technology-driven personalized medicine impacting prescription patterns.
- Global aging populations potentially driving increased demand.
- Healthcare policy reforms potentially altering accessibility and usage across regions.
Top countries in Musculo-Skeletal System Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 100.8 | 2023 | +0.2% | +0.42% | View data |
| 2 | 2 Estonia | 92.6 | 2023 | +0.98% | +2.99% | View data |
| 3 | 3 Portugal | 88.8 | 2023 | 0% | -1.15% | View data |
| 4 | 4 South Korea | 87.9 | 2023 | +2.69% | +3.73% | View data |
| 5 | 5 Chile | 80.6 | 2023 | +6.19% | +15.63% | View data |
| 6 | 6 Norway | 68.7 | 2023 | 0% | +1.91% | View data |
| 7 | 7 Slovakia | 67.5 | 2023 | -3.57% | -1.55% | View data |
| 8 | 8 Iceland | 59.6 | 2023 | +0.34% | +2.49% | View data |
| 9 | 9 Denmark | 57.2 | 2023 | +0.35% | -0.85% | View data |
| 10 | 10 Netherlands | 39.3 | 2023 | +2.61% | -0.6% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
